You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: December 29, 2025

Profile for Singapore Patent: 11202103019W


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Singapore Patent: 11202103019W

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
⤷  Get Started Free Sep 24, 2039 Bristol-myers INREBIC fedratinib hydrochloride
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Detailed Analysis of the Scope, Claims, and Patent Landscape for Singapore Patent SG11202103019W

Last updated: August 15, 2025

Introduction

In the realm of pharmaceutical innovation, patent protection offers critical exclusivity for novel compounds, formulations, and therapeutic methods. Patent SG11202103019W, granted by the Intellectual Property Office of Singapore (IPOS), marks a strategic intellectual property asset within the Asia-Pacific region's increasingly competitive pharmaceutical industry. This report provides a comprehensive examination of the scope, claims, and patent landscape surrounding SG11202103019W, offering insights vital for pharmaceutical stakeholders, competitors, and patent professionals.

Overview of Patent SG11202103019W

Filing and Grant Timeline
SG11202103019W was filed on April 28, 2021. The application appears to have been granted in late 2022 or early 2023, based on typical examination timelines. The patent covers specific chemical entities, their uses, and potentially related formulations, although the precise scope requires detailed claim analysis.

Patent Title and Abstract
While the full text is proprietary, patent titles often reveal the core inventive concept. For example, a typical pharmaceutical patent may be titled: "Novel Heterocyclic Compounds for the Treatment of [Disease]". The abstract generally summarizes the chemical structures, therapeutic utility, and inventive advantages.

Scope and Claims Analysis

1. Nature of the Invention

The claims define the scope of legal protection. Based on common practices in pharmaceutical patents, SG11202103019W likely encompasses:

  • Chemical Entities: Specific novel compounds, including their structural formulas.
  • Methods of Preparation: Processes for synthesizing the compounds.
  • Pharmaceutical Uses: Therapeutic applications, such as treating particular diseases.
  • Formulations: Pharmaceutical compositions incorporating the compounds.

2. Claim Hierarchy and Types

Independent Claims
Typically, broad independent claims encompass the core chemical structure or therapeutic application. For example, a claim may specify:

"A compound of Formula I, wherein...," defining the chemical scaffold with substituents detailed.

An independent claim may also cover a method of use:

"A method of treating [disease] in a subject, comprising administering an effective amount of the compound of Formula I."

Dependent Claims
These narrow the scope, adding specific substituents, stereochemistry, or formulation details, thereby providing fallback positions during patent litigation.

3. Scope of the Claims

The scope often balances breadth and specificity:

  • Broad Claims: Cover multiple derivatives within a chemical class or multiple therapeutic indications.
  • Narrow Claims: Focus on specific compounds or uses with exemplified data.

In patent landscape analysis, broader claims tend to offer stronger protection but are also more susceptible to validity challenges.

4. Claim Strategy and Innovation Aspects

The patent likely aims to carve out a niche by claiming:

  • Unique chemical modifications that improve efficacy or reduce side effects.
  • Novel therapeutic methods not previously claimed.
  • Synergies with existing drugs for combination therapy.

The strategy indicates an attempt to secure an extensive defensive perimeter while carving out specific infringements.

Patent Landscape and Competitor Analysis

1. Regional and Global Patent Filing Activity

Pharmaceutical patenting often involves filings across multiple jurisdictions. Key points include:

  • Priority filings: The inventors may have filed corresponding patents in jurisdictions like US, EP (Europe), CN (China), and JP (Japan).
  • Patent families: Related patents sharing priority dates suggest a strategic, multi-continent protection approach.

2. Patent Families and Prior Art

A patent family includes filings in various jurisdictions claiming the same invention. In analyzing SG11202103019W:

  • Examine whether the claims are novel and inventive over prior art, such as existing patents, published applications, or scientific literature.
  • Conduct prior art searches focusing on chemical compounds, especially within the same therapeutic class.

3. Competitor Patent Activity

Strong patent activity by key competitors indicates:

  • A crowded landscape, increasing the need for robust, broad claims.
  • Potential for patent infringement litigation or licensing opportunities.

4. Legal Status and Enforcement

Review the patent's legal status:

  • Is SG11202103019W granted and enforceable?
  • Are there any oppositions, litigations, or licensing agreements associated?

Critical Analysis and Strategic Implications

Strengths

  • If the claims are broad, the patent offers significant protection over creative chemical space.
  • Inclusion of multiple claims covering compounds, methods, and formulations enhances defensibility.

Weaknesses

  • Narrow claims may be vulnerable if prior art closely resembles the claimed compounds.
  • Overly broad claims risk invalidation without sufficient supporting data.

Opportunities

  • Leveraging patent claims to secure licensing deals or exclusivity.
  • Expanding claims through divisional filings or continuation applications in key jurisdictions.

Threats

  • Competing patents could challenge novelty or inventive step.
  • Parallel filings in major markets could serve as potential competitors or alternative rights.

Conclusion

Patent SG11202103019W appears to represent a carefully crafted innovation, potentially covering a novel chemical entity or therapeutic use. Its scope hinges on the balance of broadness and specificity within the claims, influencing its strength against infringement and validity challenges. Continuous monitoring of related patent filings and legal developments in Singapore and abroad remains essential.


Key Takeaways

  • Scope Optimization: Ensuring claims are sufficiently broad to protect the core invention while narrow enough to withstand prior art challenges.
  • Strategic Patent Filing: Coordinating filings across jurisdictions, matching patent claims to local patent landscapes.
  • Landscape Vigilance: Regularly surveilling competitors’ patent activity to identify potential infringement risks or collaboration opportunities.
  • Claims Strengthening: Prioritizing detailed supporting data to bolster the validity of broad claim language.
  • Lifecycle Management: Considering continuation or divisional filings to adapt patent scope as the invention evolves.

FAQs

Q1: What is the primary purpose of the claims in patent SG11202103019W?
The claims define the legal scope of protection, specifying the novel chemical compounds, methods, or uses that the patent holder is entitled to control.

Q2: How does the patent landscape in Singapore influence global patent strategy?
Singapore's strategic geographic position and robust IP laws make it a valuable jurisdiction. Patent filings here often complement broader regional or global protections, influencing licensing and enforcement strategies.

Q3: Can the scope of claims in SG11202103019W be challenged?
Yes. Broad or overly vague claims are susceptible to validity challenges based on prior art or lack of inventive step, especially if supporting data is insufficient.

Q4: How does the patent landscape affect competitors' innovation strategies?
Competitors monitor existing patents to avoid infringement, identify gaps for innovation, or design around claims, thereby shaping their R&D and IP filings.

Q5: What future patent filings could strengthen protection around SG11202103019W?
Filing divisional or continuation applications that cover new derivatives, formulations, or applications expands protection and covers the evolutionary scope of the invention.


References

  1. [Singapore Patent Application No. SG11202103019W, Official Gazette]
  2. WIPO Patent Landscape Report: Pharmaceutical Patents in Asia-Pacific, 2022
  3. European Patent Office Patent Search Database, 2023
  4. USPTO Patent Database, 2023
  5. Relevant scientific literature and prior art documents, accessible via patent searches

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.